ArticleClinical drug investigation2019

Response to Comments on "Pharmacokinetics, Pharmacodynamics, and Safety of the Novel Calcimimetic Agent Evocalcet in Healthy Japanese Subjects: First-in-Human Phase I Study".

Tadao Akizawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.